Imagine an ever-renewing source of immune cells that can be engineered to attack cancer and infections. The winners of this year’s Eli and Edythe Broad Innovation Award at USC are already striving to turn this exciting concept into a reality.

The collaborative research project brings together Qi-Long Ying and Rong Lu, two faculty members in the Department of Stem Cell Biology and Regenerative Medicine at USC. By combining their expertise, they hope to find better ways to cultivate the progenitor cells that eventually become two key types of immune cells: macrophages and granulocytes.

To read more, visit stemcell.keck.usc.edu/broad-innovation-award-winners-work-to-develop-cancer-immunotherapy.